YPOG advised Aignostics on the deal. Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here